Layered double hydroxide-based nanocarriers for drug delivery

Pharmaceutics

Volumn 6, Issue 2, 2014, Pages 298-332

  Bi, Xue ^a   Zhang, Hui ^a   Dou, Liguang ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

Anti cancer drug; Anti inflammatory drug; Cardiovascular drug; Controlled release; Drug delivery system; Intercalation assembly; Layered double hydroxides

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BIOMATERIAL; CARDIOVASCULAR AGENT; DRUG CARRIER; LAYERED DOUBLEHYDROXIDE BASED NANOCARRIER; NANOCARRIER; UNCLASSIFIED DRUG;

COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; MOLECULAR WEIGHT; PROCESS DEVELOPMENT; REVIEW; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING;

EID: 84902590368     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics6020298     Document Type: Review

References (117)

1. Allen, T.M.; Cullis, P.R. Drug delivery system: Entering the mainstream. Science 2004, 303, 1818-1822.
2. De, M.; Ghosh, P.S.; Rotello, V.M. Applications of nanoparticles in biology. Adv. Mater. 2008, 20, 4225-4241.
3. Bhattarai, N.; Gunn, J.; Zhang, M.Q. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Deliv. Rev. 2010, 62, 83-99.
4. Rösler, A.; Vandermeulen, G.W.M.; Klok, H.-A. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv. Drug Deliv. Rev. 2012, 64, 270-279.
5. Kataoka, K.; Harada, A.; Nagasaki, Y. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv. Drug Deliver. Rev. 2012, 64, 37-48.
6. Qiu, Y.; Park, K. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev. 2012, 64, 49-60.
7. Siepmann, J.; Peppas, N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 2012, 64, 163-174.
8. Alvarez-Lorenzo, C.; Blanco-Fernandez, B.; Puga, A.M.; Concheiro, A. Crosslinked ionic polysaccharides for stimuli-sensitive drug delivery. Adv. Drug Deliv. Rev. 2013, 65, 1148-1171.
9. Zhang, N.; Wardwell, P.R.; Bader, R.A. Polysaccharide-based micelles for drug delivery. Pharmaceutics 2013, 5, 329-352.
10. Lawrence, M.J.; Rees, G.D. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 2012, 64, 175-193.
11. Yoo, J.-W.; Irvine, D.J.; Discher, D.E.; Mitragotri, S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 2011, 10, 521-535.
12. Tang, F.Q.; Li, L.L.; Chen, D. Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv. Mater. 2012, 24, 1504-1534.
13. Yang, P.P.; Gai, S.L.; Lin, J. Functionalized mesoporous silica materials for controlled drug delivery. Chem. Soc. Rev. 2012, 41, 3679-3698.
14. Alexis, F.; Pridgen, E.M.; Langer, R.; Farokhzad, O.C. Nanoparticle technologies for cancer therapy. Handb. Exp. Pharmacol. 2010, 197, 55-86.
15. Wei, P.-R.; Cheng, S.-H.; Liao, W.-N.; Kao, K.-C.; Weng, F.-C.; Lee, C.-H. Synthesis of chitosan-coated near-infrared layered double hydroxide nanoparticles for in vivo optical imaging. J. Mater. Chem. 2012, 22, 5503-5513.
16. Ribeiro, L.N.M.; Alcântara, A.C.S.; Darder, M.; Aranda, P.; Araújo-Moreira, F.M.; Ruiz-Hitzky, E. Pectin-coated chitosan-LDH bionanocomposite beads as potential systems for colon-targeted drug delivery. Int. J. Pharm. 2014, 463, 1-9.
17. Pan, D.K.; Zhang, H.; Zhang, T.; Duan, X. A novel organic-inorganic microhybrids containing anticancer agent doxifluridine and layered double hydroxides: Structure and controlled release properties. Chem. Eng. Sci. 2010, 65, 3762-3771.
18. Aguzzi, C.; Cerezo, P.; Viseras, C.; Caramella, C. Use of clays as drug delivery systems: Possibilities and limitations. Appl. Clay Sci. 2007, 36, 22-36.
19. Cavani, F.; Trifirò, F.; Vaccari, A. Hydrotalcite-type anionic clays: Preparation, properties and applications. Catal. Today 1991, 11, 173-301.
20. Khan, A.I.; O'Hare, D. Intercalation chemistry of layered double hydroxides: Recent developments and applications. J. Mater. Chem. 2002, 12, 3191-3198.
21. Evans, D.G.; Duan, X. Preparation of layered double hydroxides and their applications as additives in polymers, as precursors to magnetic materials and in biology and medicine. Chem. Commun. 2006, doi:10.1039/B510313B.
22. Williams, G.R.; O'Hare, D. Towards understanding, control and application of layered double hydroxide chemistry. J. Mater. Chem. 2006, 16, 3065-3074.
23. Wang, Q.; O'Hare, D. Recent advances in the synthesis and application of layered double hydroxide (LDH) nanosheets. Chem. Rev. 2012, 112, 4124-4155.
24. Xu, Z.P.; Stevenson, G.S.; Lu, C.Q.; Lu, G.Q.; Bartlett, P.F.; Gray, P.P. Stable suspension of layered double hydroxide nanoparticles in aqueous solution. J. Am. Chem. Soc. 2006, 128, 36-37.
25. Sideris, P.J.; Nielsen, U.G.; Gan, Z.H.; Grey, C.P. Mg/Al ordering in layered double hydroxides revealed by multinuclear NMR spectroscopy. Science 2008, 321, 113-117.
26. Centi, G.; Perathoner, S. Catalysis by layered materials: A review. Microporous Mesoporous Mater. 2008, 107, 3-15.
27. Del Hoyo, C. Layered double hydroxides and human health: An overview. Appl. Clay Sci. 2007, 36, 103-121.
28. Ladewig, K.; Xu, Z.P.; Lu, G.Q. Layered double hydroxide nanoparticles in gene and drug delivery. Expert Opin. Drug Deliv. 2009, 6, 907-922.
29. Goh, K.-H.; Lim, T.-T.; Dong, Z.L. Application of layered double hydroxides for removal of oxyanions: A review. Water Res. 2008, 42, 1343-1368.
30. Zou, K.; Zhang, H.; Duan, X. Studies on the formation of 5-aminosalicylate intercalated Zn-Al layered double hydroxides as a function of Zn/Al molar ratios and synthesis routes. Chem. Eng. Sci. 2007, 62, 2022-2031.
31. Leroux, F.; Besse, J.-P. Polymer interleaved layered double hydroxide: A new emerging class of nanocomposites. Chem. Mater. 2001, 13, 3507-3515.
32. Alcântara, A.C.S.; Aranda, P.; Darder, M.; Ruiz-Hitzky, E. Bionanocomposites based on alginate-zein/layered double hydroxide materials as drug delivery systems. J. Mater. Chem. 2010, 20, 9495-9504.
33. Miao, Y.-E.; Zhu, H.; Chen, D.; Wang, R.Y.; Tjiu, W.W.; Liu, T.X. Electrospun fibers of layered double hydroxide/biopolymer nanocomposites as effective drug delivery systems. Mater. Chem. Phys. 2012, 134, 623-630.
34. Chakraborti, M.; Jackson, J.K.; Plackett, D.; Brunette, D.M.; Burt, H.M. Drug intercalation in layered double hydroxide clay: Application in the development of a nanocomposite film for guided tissue regeneration. Int. J. Pharm. 2011, 416, 305-313.
35. Bugatti, V.; Gorrasi, G.; Montanari, F.; Nocchetti, M.; Tammaro, L.; Vittoria, V. Modified layered double hydroxides in polycaprolactone as a tunable delivery system: In vitro release of antimicrobial benzoate derivatives. Appl. Clay Sci. 2011, 52, 34-40.
36. 2) and its application in drug delivery. Nanoscale 2011, 3, 4069-4073.
37. Liu, J.; Harrison, R.; Zhou, J.Z.; Liu, T.T.; Yu, C.Z.; Lu, G.Z.; Qiao, S.Z.; Xu, Z.P. Synthesis of nanorattles with layered double hydroxide core and mesoporous silica shell as delivery vehicles. J. Mater. Chem. 2011, 21, 10641-10644.
38. Zhang, H.; Zou, K.; Sun, H.; Duan, X. A magnetic organic-inorganic composite: Synthesis and characterization of magnetic 5-aminosalicylic acid intercalated layered double hydroxides. J. Solid State Chem. 2005, 178, 3485-3493.
39. Zhou, L.L.; Yuan, J.Y.; Wei, Y. Core-shell structural iron oxide hybrid nanoparticles: From controlled synthesis to biomedical applications. J. Mater. Chem. 2011, 21, 2823-2840.
40. 4@DFUR-LDH submicro particles for magnetically controlled drug delivery and release. Chem. Commun. 2011, 47, 908-910.
41. Oh, M.-J.; Biswick, T.T.; Choy, J.-H. Layered nanomaterials for green materials. J. Mater. Chem. 2009, 19, 2553-2563.
42. Gunawan, P.; Xu, R. Direct assembly of anisotropic layered double hydroxide (LDH) nanocrystals on spherical template for fabrication of drug-LDH hollow nanospheres. Chem. Mater. 2009, 21, 781-783.
43. Huang, W.; Zhang, H.; Pan, D.K. Study on the release behavior and mechanism by monitoring the morphology changes of the large-sized drug-LDH nanohybrids. AIChE J. 2011, 57, 1936-1946.
44. Tarnawski, A.S.; Tomikawa, M.; Ohta, M.; Sarfeh, I.J. Antacid talcid activates in gastric mucosa genes encoding for EGF and its receptor. The molecular basis for its ulcer healing action. J. Physiol. Paris 2000, 94, 93-98.
45. Khan, A.I.; Ragavan, A.; Fong, B.; Markland, C.; O'Brien, M.; Dunbar, T.G.; Williams, G.R.; O'Hare, D. Recent developments in the use of layered double hydroxides as host materials for the storage and triggered release of functional anions. Ind. Eng. Chem. Res. 2009, 48, 10196-10205.
46. Choi, S.-J.; Oh, J.-M.; Choy, J.-H. Biocompatible nanoparticles intercalated with anticancer drug for target delivery: Pharmacokinetic and biodistribution study. J. Nanosci. Nanotechnol. 2010, 10, 2913-2916.
47. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2012, 64, 61-71.
48. Choy, J.-H.; Jung, J.-S.; Oh, J.-M.; Park, M.; Jeong, J.; Kang, Y.-K.; Han, O.-J. Layered double hydroxide as an efficient drug reservoir for folate derivatives. Biomaterials 2004, 25, 3059-3064.
49. Posati, T.; Bellezza, F.; Tarpani, L.; Perni, S.; Latterini, L.; Marsili, V.; Cipiciani, A. Selective internalization of ZnAl-HTlc nanoparticles in normal and tumor cells. A study of their potential use in cellular delivery. Appl. Clay Sci. 2012, 55, 62-69.
50. Oh, J.-M.; Choi, S.-J.; Kim, S.-T.; Choy, J.-H. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: Enhanced efficacy due to clathrin-mediated endocytosis. Bioconjug. Chem. 2006, 17, 1411-1417.
51. Choi, S.-J.; Oh, J.-M.; Choy, J.-H. Human-related application and nanotoxicology of inorganic particles: Complementary aspects. J. Mater. Chem. 2008, 18, 615-620.
52. Choi, S.-J.; Oh, J.M.; Choy, J.-H. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J. Inorg. Biochem. 2009, 103, 463-471.
53. Choi, S.-J.; Choy, J.-H. Layered double hydroxide nanoparticles as target-specific delivery carriers: Uptake mechanism and toxicity. Nanomedicine 2011, 6, 803-814.
54. Nel, A.; Xia, T.; Mädler, L.; Li, N. Toxic potential of materials at the nanolevel. Science 2006, 311, 622-627.
55. Choi, S.-J.; Oh, J.-M.; Choy, J.-H. Safety aspect of inorganic layered nanoparticles: Size-dependency in vitro and in vivo. J. Nanosci. Nanotechnol. 2008, 8, 5297-5301.
56. Baek, M.; Kim, I.-S.; Yu, J.; Chung, H.E.; Choy, J.-H.; Choi, S.-J. Effect of different forms of anionic nanoclays on cytotoxicity. J. Nanosci. Nanotechnol. 2011, 11, 1803-1806.
57. Khan, A.I.; Lei, L.X.; Norquist, A.J.; O'Hare, D. Intercalation and controlled release of pharmaceutically active compounds from a layered double hydroxide. Chem. Commun. 2001, doi:10.1039/B106465G.
58. Zhang, H.; Zou, K.; Guo, S.H.; Duan, X. Nanostructural drug-inorganic clay composites: Structure, thermal property and in vitro release of captopril-intercalated Mg-Al-layered double hydroxides. J. Solid State Chem. 2006, 179, 1791-1800.
59. Gu, Z.; Thomas, A.C.; Xu, Z.P.; Campbell, J.H.; Lu, G.Q. In vitro sustained release of LMWH from MgAl-layered double hydroxide nanohybrids. Chem. Mater. 2008, 20, 3715-3722.
60. Panda, H.S.; Strivastava, R.; Bahadur, D. In vitro release kinetics and stability of anticardiovascular drugs-intercalated layered double hydroxide nanohybrids. J. Phys. Chem. B 2009, 113, 15090-15100.
61. Berber, M.R.; Hafez, I.H.; Minagawa, K.; Mon, T.; Tanaka, M. Nanocomposite formulation system of lipid-regulating drugs based on layered double hydroxide: Synthesis, characterization and drug release properties. Pharm. Res. 2010, 27, 2394-2401.
62. Rives, V.; del Arco, M.; Martín, C. Layered double hydroxides as drug carriers and for controlled release of non-steroidal antiinflammatory drugs (NSAIDs): A review. J. Control. Release 2013, 169, 28-39.
63. Ambrogi, V.; Fardella, G.; Grandolini, G.; Perioli, L. Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents-I. Intercalation and in vitro release of ibuprofen. Int. J. Pharm. 2001, 220, 23-32.
64. Gordijo, C.R.; Barbose, C.A.S.; da Costa Ferreira, A.M.; Constantino, V.R.L.; de Oliveira Silva, D. Immobilization of ibuprofen and copper-ibuprofen drugs on layered double hydroxides. J. Pharm. Sci. 2005, 94, 1135-1148.
65. Mohanambe, L.; Vasudevan, S. Anionic clays containing anti-inflammatory drug molecules: Comparison of molecular dynamics simulation and measurements. J. Phys. Chem. B 2005, 109, 15651-15658.
66. Gunawan, P.; Xu, R. Direct control of drug release behavior from layered double hydroxides through particle interactions. J. Pharm. Sci. 2008, 97, 4367-4378.
67. Deleon, V.H.; Nguyen, T.D.; Nar, M.; D'Souza, N.A.; Golden, T.D. Polymer nanocomposites for improved drug delivery efficiency. Mater. Chem. Phys. 2012, 132, 409-415.
68. Wei, M.; Shi, S.X.; Wang, J.; Li, Y.; Duan, X. Studies on the intercalation of naproxen into layered double hydroxide and its thermal decomposition by in situ FT-IR and in situ HT-XRD. J. Solid State Chem. 2004, 177, 2534-2541.
69. Berber, M.R.; Minagawa, K.; Katoh, M.; Mori, T.; Tanaka, M. Nanocomposites of 2-arylpropionic acid drugs based on Mg-Al layered double hydroxide for dissolution enhancement. Eur. J. Pharm. Sci. 2008, 35, 354-360.
70. Del Arco, M.; Fernández, A.; Martín, C.; Rives, V. Release studies of different NSAIDs encapsulated in Mg, Al, Fe-hydrotalcites. Appl. Clay Sci. 2009, 42, 538-544.
71. Carriazo, D.; del Arco, M.; Martín, C.; Ramos, C.; Rives, V. Influence of the inorganic matrix nature on the sustained release of naproxen. Microporous Mesoporous. Mater. 2010, 130, 229-238.
72. Hou, W.G.; Jin, Z.L. Synthesis and characterization of Naproxen intercalated Zn-Al layered double hydroxides. Colloid Polym. Sci. 2007, 285, 1449-1454.
73. Ambrogi, V.; Perioli, L.; Ricci, M.; Pulcini, L.; Nocchetti, M.; Giovagnoli, S.; Rossi, C. Eudragit® and hydrotalcite-like anionic clay composite system for diclofenac colonic delivery. Microporous Mesoporous Mater. 2008, 115, 405-415.
74. Perioli, L.; Posati, T.; Nocchetti, M.; Bellezza, F.; Costantino, U.; Cipiciani, A. Intercalation and release of antiinflammatory drug diclofenac into nanosized ZnAl hydrotalcite-like compound. Appl. Clay Sci. 2011, 53, 374-378.
75. San Román, M.S.; Holgado, M.J.; Salinas, B.; Rives, V. Characterisation of diclofenac, ketoprofen or chloramphenicol succinate encapsulated in layered double hydroxides with the hydrotalcite-type structure. Appl. Clay Sci. 2012, 55, 158-163.
76. San Román, M.S.; Holgado, M.J.; Salinas, B.; Rives, V. Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites. Appl. Clay Sci. 2013, 71, 1-7.
77. Li, B.X.; He, J.; Evans, D.G.; Duan, X. Inorganic layered double hydroxides as a drug delivery system-Intercalation and in vitro release of fenbufen. Appl. Clay Sci. 2004, 27, 199-207.
78. Li, B.X.; He, J.; Evans, D.G.; Duan, X. Enteric-coated layered double hydroxides as a controlled release drug delivery system. Int. J. Pharm. 2004, 287, 89-95.
79. Del Arco, M.; Fernández, A.; Martín, C.; Rives, V. Solubility and release of fenbufen intercalated in Mg, Al and Mg, Al, Fe layered double hydroxides (LDH): The effect of Eudragit® S 100 covering. J. Solid State Chem. 2010, 183, 3002-3009.
80. Perioli, L.; Ambrogi, V.; Nauta, L.; Nocchetti, M.; Rossi, C. Effects of hydrotalcite-like nanostructured compounds on biopharmaceutical properties and release of BCS class II drugs: The case of flurbiprofen. Appl. Clay Sci. 2011, 51, 407-413.
81. Kim, M.H.; Park, D.H.; Yang, J.H.; Choy, Y.B.; Choy, J.H. Drug-inorganic-polymer nanohybrid for transdermal delivery. Int. J. Pharm. 2013, 444, 120-127.
82. Del Arco, M.; Cebadera, E.; Gutiérrez, S.; Martín, C.; Montero, M.J.; Rives, V.; Rocha, J.; Sevilla, M.A. Mg, Al layered double hydroxides with intercalated indomethacin: Synthesis, characterization, and pharmacological study. J. Pharm. Sci. 2004, 93, 1649-1658.
83. Del Arco, M.; Fernández, A.; Martín, C.; Rives, V. Intercalation of mefenamic and meclofenamic acid anions in hydrotalcite-like matrixes. Appl. Clay Sci. 2007, 36, 133-140.
84. Sahoo, P.K.; Panda, H.S.; Bahadur, D. Studies on the stability and kinetics of drug release of dexamethasone phosphate intercalated layered double hydroxides nanohybrids. Mater. Chem. Phys. 2013, 142, 106-112.
85. Riaz, U.; Ashraf, S.M. Double layered hydroxides as potential anti-cancer drug delivery agents. Mini Rev. Med. Chem. 2013, 13, 522-529.
86. Oh, J.-M.; Park, M.; Kim, S.-T.; Jung, J.-Y.; Kang, Y.-G.; Choy, J.-H. Efficient delivery of anticancer drug MTX through MTX-LDH nanohybrid system. J. Phys. Chem. Solids 2006, 67, 1024-1027.
87. Kim, J.Y.; Choi, S.-J.; Oh, J.-M.; Park, T.; Choy, J.-H. Anticancer drug-inorganic nanohybrid and its cellular interaction. J. Nanosci. Nanotechnol. 2007, 7, 3700-3705.
88. Choi, S.-J.; Choi, G.E.; Oh, J.-M.; Oh, Y.-J.; Park, M.-C.; Choy, J.-H. Anticancer drug encapsulated in inorganic lattice can overcome drug resistance. J. Mater. Chem. 2010, 20, 9463-9469.
89. Chakraborty, M.; Dasgupta, S.; Bose, P.; Misra, A.; Mandal, T.K.; Mitra, M.; Chakraborty, J.; Basu, D. Layered double hydroxide: Inorganic organic conjugate nanocarrier for methotrexate. J. Phys. Chem. Solids 2011, 72, 779-783.
90. Chakraborty, M.; Dasgupta, S.; Soundrapandian, C.; Chakraborty, J.; Ghosh, S.; Mitra, M.K.; Basu, D. Methotrexate intercalated ZnAl-layered double hydroxide. J. Solid State Chem. 2011, 184, 2439-2445.
91. Chakraborty, M.; Dasgupta, S.; Sengupta, S.; Chakraborty, J.; Ghosh, S.; Ghosh, J.; Mitra, M.K.; Mishra, A.; Mandal, T.K.; Basu, D. A facile synthetic strategy for Mg-Al layered double hydroxide material as nanocarrier for methotrexate. Ceram. Int. 2012, 38, 941-949.
92. Chakraborty, J.; Roychowdhury, S.; Sengupta, S.; Ghosh, S. Mg-Al layered double hydroxide-methotrexate nanohybrid drug delivery system: Evaluation of efficacy. Mater. Sci. Eng. C 2013, 33, 2168-2174.
93. Yan, L.; Chen, W.; Zhu, X.Y.; Huang, L.B.; Wang, Z.G.; Zhu, G.Y.; Roy, V.A.L.; Yu, K.N.; Chen, X.F. Folic acid conjugated self-assembled layered double hydroxide nanoparticles for high-efficacy-targeted drug delivery. Chem. Commun. 2013, 49, 10938-10940.
94. 2Al layered double hydroxides containing 5-fluorouracil. J. Solid State Chem. 2005, 178, 736-741.
95. Choi, S.-J.; Oh, J.-M.; Choy, J.-H. Anticancer drug-layered hydroxide nanohybrids as potent cancer chemotherapy agents. J. Phys. Chem. Solids 2008, 69, 1528-1532.
96. Jin, L.; Liu, Q.; Sun, Z.Y.; Ni, X.Y.; Wei, M. Preparation of 5-fluorouracil/β-cyclodextrin complex intercalated in layered double hydroxide and the controlled drug release properties. Ind. Eng. Chem. Res. 2010, 49, 11176-11181.
97. Chen, C.P.; Yee, L.K.; Gong, H.; Zhang, Y.; Xu, R. A facile synthesis of strong near infrared fluorescent layered double hydroxide nanovehicles with an anticancer drug for tumor optical imaging and therapy. Nanoscale 2013, 5, 4314-4320.
98. Tyner, K.M.; Schiffman, S.R.; Giannelis, E.P. Nanobiohybrids as delivery vehicles for camptothecin. J. Control. Release 2004, 95, 501-514.
99. Dong, L.; Li, Y.; Hou, W.G.; Liu, S.J. Synthesis and release behavior of composites of camptothecin and layered double hydroxide. J. Solid State Chem. 2010, 183, 1811-1816.
100. Pang, X.J.; Ma, X.M.; Li, D.X.; Hou, W.G. Synthesis and characterization of 10-hydroxycamptothecin-sebacate-layered double hydroxide nanocomposites. Solid State Sci. 2013, 16, 71-75.
101. Wang, Z.L.; Wang, E.B.; Tian, S.Y.; Xiao, D.R. Intercalation of PM-19 into and in vitro release of anti-tumor drug from layered double hydroxide. Chem. Res. Chin. Univ. 2005, 21, 492-495.
102. Qin, L.L.; Xue, M.; Wang, W.R.; Zhu, R.R.; Wang, S.L.; Sun, J.; Zhang, R.; Sun, X.Y. The in vitro and in vivo anti-tumor effect of layered double hydroxides nanoparticles as delivery for podophyllotoxin. Int. J. Pharm. 2010, 388, 223-230.
103. Wang, L.J.; Xing, H.Y.; Zhang, S.J.; Ren, Q.G.; Pan, L.M.; Zhang, K.; Bu, W.B.; Zhang, X.P.; Zhou, L.P.; Peng, W.J.; et al. A Gd-doped Mg-Al-LDH/Au nanocomposite for CT/MRI bimodal imagings and simultaneous drug delivery. Biomaterials 2013, 34, 3390-3401.
104. Rives, V.; del Arco, M.; Martin, C. Intercalation of drugs in layered double hydroxides and their controlled release: A review. Appl. Clay Sci. 2014, 88-89, 239-269.
105. Hussein-Al-Ali, S.H.; Al-Qubaisi, M.; Hussein, M.Z.; Ismail, M.; Zainal, Z.; Hakim, M.Z. In vitro inhibition of histamine release behavior of cetirizine intercalated into Zn/Al-and Mg/Al-layered double hydroxides. Int. J. Mol. Sci. 2012, 13, 5899-5916.
106. Kong, X.G.; Jin, L.; Wei, M.; Duan, X. Antioxidant drugs intercalated into layered double hydroxide: Structure and in vitro release. Appl. Clay Sci. 2010, 49, 324-329.
107. Kong, X.G.; Shi, S.X.; Han, J.B.; Zhu, F.J.; Wei, M.; Duan, X. Preparation of Glycy-L-tyrosine intercalated layered double hydroxide film and its in vitro release behavior. Chem. Eng. J. 2010, 157, 598-604.
108. Wei, M.; Yuan, Q.; Evans, D.G.; Wang, Z.Q.; Duan, X. Layered solid as a "molecular container" for pharmaceutical agent: L-Tyrosine-intercalated layered double hydroxides. J. Mater. Chem. 2005, 15, 1197-1203.
109. Ay, A.N.; Zümreoglu-Karan, B.; Temel, A.; Rives, V. Bioinorganic magnetic core-shell nanocomposites carrying antiarthritic agents: Intercalation of ibuprofen and glucuronic acid into Mg-Al-layered double hydroxides supported on magnesium ferrite. Inorg. Chem. 2009, 48, 8871-8877.
110. Wang, J.; Zhou, J.D.; Li, Z.S.; Song, Y.C.; Liu, Q.; Jiang, Z.H.; Zhang, M.L. Magnetic, luminescent Eu-doped Mg-Al layered double hydroxide and its intercalation for ibuprofen. Chem. Eur. J. 2010, 16, 14404-14411.
111. Panda, H.S.; Bahadur, D. Study of the preparation, properties and kinetics of anion release in drug intercalated magnetic nanohybrids. Mater. Res. Bull. 2012, 47, 571-579.
112. Kim, J.-E.; Shin, J.-Y.; Cho, M.-H. Magnetic nanoparticles: An update of application for drug delivery and possible toxic effects. Arch. Toxicol. 2012, 86, 685-700.
113. Kumar, C.S.S.R.; Mohammad, F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv. Drug Deliv. Rev. 2011, 63, 789-808.
114. Deng, H.; Li, X.L.; Peng, Q.; Wang, X.; Chen, J.P.; Li, Y.D. Monodisperse magnetic single-crystal ferrite microspheres. Angew. Chem. Int. Ed. 2005, 44, 2782-2785.
115. 4 submicroparticles with controlled particle sizes. Ind. Eng. Chem. Res. 2011, 50, 9009-9018.
116. Zhang, H.; Pan, D.K.; Zou, K.; He, J.; Duan, X. A novel core-shell structured magnetic organic-inorganic nanohybrid involving drug-intercalated layered double hydroxides coated on a magnesium ferrite core for magnetically controlled drug release. J. Mater. Chem. 2009, 19, 3069-3077.
117. Zhang, H.; Pan, D.K.; Duan, X. Synthesis, characterization, and magnetically controlled release behavior of novel core-shell structural magnetic ibuprofen-intercalated LDH nanohybrids. J. Phys. Chem. C 2009, 113, 12140-12148.